ZERO DIABETES WORLD

VALBIOTIS specializes in developing innovative nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients.

Valedia®

A world premiere for 527 million prediabetics. After a positive Clinical Phase I/II, Phase IIa is underway. Three additional studies will be conducting in Europe, the United States and Canada included more than 400 prediabetics subjects.

Our product Valedia

News